Panbela Therapeutics Inc. buy Maxim Group
Start price
20.03.23
/
50%
€6.36
Target price
20.03.24
-
Performance (%)
-96.67%
End price
21.03.24
-
Summary
This prediction is currently being closed. Massive losses of -96.67% have been the result for the BUY prediction by Maxim_Group. Maxim_Group has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Panbela Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % | 49,79 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % | 88,25 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % | 61,92 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % | 63,54 % |
Comments by Maxim_Group for this prediction
In the thread Panbela Therapeutics Inc. diskutieren
Panbela Therapeutics, Inc. (NASDAQ: PBLA) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for PBLA provided by MarketBeat
In the thread Trading Panbela Therapeutics Inc.
Die von Maxim_Group gewählte maximale Laufzeit wurde überschritten